𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase I Cancer Clinical Trials

✍ Scribed by Ledermann, J A

Book ID
109999123
Publisher
Nature Publishing Group
Year
2007
Tongue
English
Weight
41 KB
Volume
96
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

An evaluation of phase I cancer clinical
An evaluation of phase I cancer clinical trial designs
✍ Chul Ahn πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 88 KB πŸ‘ 2 views

Phase I clinical trials are designed to identify an appropriate dose for experimentation in phase II and III studies. I present the results from a simulation study to evaluate the performance of nine phase I designs involving the standard design, the two-stage modified Storer's design, the two-stage

Cancer phase I clinical trials: efficien
Cancer phase I clinical trials: efficient dose escalation with overdose control
✍ James Babb; AndrΓ© Rogatko; Shelemyahu Zacks πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 172 KB πŸ‘ 1 views

We describe an adaptive dose escalation scheme for use in cancer phase I clinical trials. The method is fully adaptive, makes use of all the information available at the time of each dose assignment, and directly addresses the ethical need to control the probability of overdosing. It is designed to

The conduct of phase I-II clinical trial
The conduct of phase I-II clinical trials in children with cancer
✍ Pratt, Charles B. πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 677 KB

Phase I Clinical Trials in children with cancer are carried out with therapeutic intent, so as to define antileukemic/antitumor activity, dose-limiting toxicity, maximum tolerated dosage, and pharmacokinetics. These studies define a dosage of an agent or combination that may be used in a larger stud

Photo-induced cytomorphologic changes in
Photo-induced cytomorphologic changes in an advanced cancer phase I clinical trial
✍ Luis A. Santana-Blank; Elizabeth RodrΓ­guez-Santana; Fernando Vargas; Karin E. Sa πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 265 KB

## Abstract ## Background and Objectives The aim of this study was to investigate whether the application of an Infrared Pulsed Laser Device (IPLD) photo‐induced significant cytomorphologic changes during the monitoring of advanced cancer patients participating in a phase I clinical trial. ## Mat

Preclinical safety testing of DISC-hGMCS
Preclinical safety testing of DISC-hGMCSF to support phase I clinical trials in cancer patients
✍ Peter T. Loudon; Diane M. Blakeley; Mike E. G. Boursnell; Debbie A. Day; Imogen πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 235 KB

## Background: Disc-hgmcsf is a gh-deleted hsv-2 based vector expressing human gm-csf that is being developed for cancer immunotherapy. to support first clinical use, a range of preclinical safety studies were performed using disc-hgmcsf in addition to disc-murine-gmcsf and the backbone vector, ta-